SCHEMBL4886102

SCHEMBL4886102

Clc1cc(Cl)c(Cl)c(B(c2c(Cl)c(Cl)cc(Cl)c2Cl)c2c(Cl)c(Cl)cc(Cl)c2Cl)c1Cl

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.53
HPGD P15428 7/20 0.45
HSD17B10 Q99714 7/20 0.45
TSHR P16473 7/20 0.45
CASP1 P29466 1/20 0.45
ALDH1A1 P00352 3/20 0.42
MAPK1 P28482 3/20 0.41
CRHBP P24387 1/20 0.38
CRHR2 Q13324 1/20 0.38
AHR P35869 8/20 0.38
HSP90AA1 P07900 2/20 0.35
MEN1 O00255 1/20 0.35
NPC1 O15118 1/20 0.35
USP2 O75604 1/20 0.35
EGFR P00533 1/20 0.35
LMNA P02545 1/20 0.35
ESR1 P03372 1/20 0.35
ERBB2 P04626 1/20 0.35
CYP1A2 P05177 1/20 0.35
LCK P06239 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4885560 0.81 CYP3A4 (0.56) CYP3A4HPGDHSD17B10TSHRCASP1
SCHEMBL4887314 0.75 NPC1 (0.38) CYP3A4HPGDHSD17B10TSHRCASP1
SCHEMBL4886870 0.75 NPC1 (0.42) CYP3A4ALDH1A1MAPK1HSP90AA1MEN1
SCHEMBL2555771 0.75 HPGD (0.48) CYP3A4HPGDHSD17B10TSHRCASP1
SCHEMBL4885803 0.75 CYP3A4 (0.41) CYP3A4HPGDHSD17B10TSHRCASP1
SCHEMBL4889741 0.71 LMNA (0.36) CYP3A4HPGDHSD17B10TSHRALDH1A1
SCHEMBL4879485 0.71 HTT (0.39) CYP3A4HPGDALDH1A1MAPK1MEN1
SCHEMBL4892213 0.70 MEN1 (0.31) HPGDHSD17B10TSHRALDH1A1MEN1
Pentachlorobenzene SCHEMBL11455164 0.70 CYP3A4 (1.00) CYP3A4HPGDHSD17B10TSHRCASP1
Pentachlorobenzene SCHEMBL183144 0.70 CYP3A4 (1.00) CYP3A4HPGDHSD17B10TSHRCASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1817318-B1 STABILIZING METHOD AND STABILIZED COMPOSITION FOR ARYL BORON COMPOUNDS NIPPON CATALYTIC CHEM IND (JP) 2013-08-28 EP disclosed
US-20080154065-A1 Stabilizing Method and Stabilized Composition for Aryl Boron Compounds NIPPON SHOKUBAI CO., LTD. (JP) 2008-06-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080154065-A1 Stabilizing Method and Stabilized Composition for Aryl Boron Compounds AR, AHR, BCL6 CYP3A4 2401/4885HPGD 4745/4885HSD17B10 1684/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.